EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Toxoplasma Effector GRA4 Hijacks Host TBK1 to Oppositely Regulate Anti‐ T. Gondii Immunity and Tumor Immunotherapy

Zhiqiang Hu, Yufen Zhang, Yingchao Xie, Jianwu Yang, Haotian Tang, Bolin Fan, Ke Zeng, Zhongxin Han, Jiansen Lu, Huaji Jiang, Wenqiang Peng, Hongyu Li und 5 weitere

Advanced Science · 2024

DOI: 10.1002/advs.202400952 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2024. Verfasst von Zhiqiang Hu und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, China. Hauptthemen laut MEDLINE: Immunotherapy, Protein Serine-Threonine Kinases, Protozoan Proteins, Toxoplasma. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Postdoctoral Research Foundation of China, Basic and Applied Basic Research Foundation of Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Toxoplasma gondii ( T. gondii )‐associated polymorphic effector proteins are crucial in parasite development and regulating host anti‐ T. gondii immune responses. However, the mechanism remains obscure. Here, it is shown that Toxoplasma effector dense granules 4 (GRA4) restricts host IFN‐I activation. Infection with Δ gra4 mutant T. gondii strain induces stronger IFN‐I responses and poses a severe threat to host health. Mechanistically, GRA4 binds to phosphorylated TBK1 to promote TRIM27‐catalyzed K48‐ubiquitination at Lys251/Lys372 residues, which enhances its recognition by autophagy receptor p62, ultimately leading to TBK1 autophagic degradation. Furthermore, an avirulent Δ gra4 strain (ME49Δ ompdc / gra4 ) is constructed for tumor immunotherapy due to its ability to enhance IFN‐I production. Earlier vaccination with ME49Δ ompdc / gra4 confers complete host resistance to the tumor compared with the classical ME49Δ ompdc treatment. Notably, ME49Δ ompdc / gra4 vaccination induces a specific CD64 + MAR‐1 + CD11b + dendritic cell subset, thereby enhancing T cell anti‐tumor responses. Overall, these findings identify the negative role of T. gondii GRA4 in modulating host IFN‐I signaling and suggest that GRA4 can be a potential target for the development of T. gondii vaccines and tumor immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunotherapyProtein Serine-Threonine KinasesProtozoan ProteinsToxoplasmaAnimalsFemaleMaleMiceDisease Models, AnimalMice, Inbred C57BLNeoplasmsToxoplasmosis

Stichwörter der Autor:innen

attenuated T. gondiiselective autophagytoxoplasmosistumor therapytype I interferon

Substanzen

Protein Serine-Threonine KinasesProtozoan ProteinsTbk1 protein, mouse

Autor:innen und Institutionen

  • Department of Immunology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, China.
  • Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Institute of Translational Medicine, Zhejiang University School of Medicine, Zhejiang University, Hangzhou, 310029, China.
  • State Key Laboratory of Biocontrol, School of Life Sciences, Sun Yat-sen University, Guangzhou, 510275, China.
  • State Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, 430070, China.
  • Department of Joint Surgery, the Fifth Affiliated Hospital of Southern Medical University, Guangzhou, 510900, China.
  • Yue Bei People's Hospital Postdoctoral Innovation Practice Base, Southern Medical University, Guangzhou, 510515, China.

ORCID-Profile: Xiao Yu

Förderung

  • National Natural Science Foundation of China
  • Postdoctoral Research Foundation of China
  • Basic and Applied Basic Research Foundation of Guangdong Province

Zitieren

APA

Hu, Z., Zhang, Y., Xie, Y., Yang, J., Tang, H., Fan, B., Zeng, K., Han, Z., Lu, J., Jiang, H., Peng, W., Li, H., Chen, H., Wu, S., Shen, B., Lun, Z. R., & Yu, X. (2024). The Toxoplasma Effector GRA4 Hijacks Host TBK1 to Oppositely Regulate Anti‐ T. Gondii Immunity and Tumor Immunotherapy. Advanced Science. https://doi.org/10.1002/advs.202400952

Vancouver

Hu Z, Zhang Y, Xie Y, Yang J, Tang H, Fan B, et al. The Toxoplasma Effector GRA4 Hijacks Host TBK1 to Oppositely Regulate Anti‐ T. Gondii Immunity and Tumor Immunotherapy. Advanced Science. 2024. doi:10.1002/advs.202400952

BibTeX
@article{Hu2024,
  author = {Hu, Zhiqiang and Zhang, Yufen and Xie, Yingchao and Yang, Jianwu and Tang, Haotian and Fan, Bolin and Zeng, Ke and Han, Zhongxin and Lu, Jiansen and Jiang, Huaji and Peng, Wenqiang and Li, Hongyu and Chen, Huadan and Wu, Sha and Shen, Bang and Lun, Zhao-Rong and Yu, Xiao},
  title = {The Toxoplasma Effector GRA4 Hijacks Host TBK1 to Oppositely Regulate Anti‐ T. Gondii Immunity and Tumor Immunotherapy},
  journal = {Advanced Science},
  year = {2024},
  doi = {10.1002/advs.202400952}
}
Kostenlos starten →